PE20081142A1 - Formulaciones semisolidas de inhibidores de enzima fosfolipasa - Google Patents

Formulaciones semisolidas de inhibidores de enzima fosfolipasa

Info

Publication number
PE20081142A1
PE20081142A1 PE2007001496A PE2007001496A PE20081142A1 PE 20081142 A1 PE20081142 A1 PE 20081142A1 PE 2007001496 A PE2007001496 A PE 2007001496A PE 2007001496 A PE2007001496 A PE 2007001496A PE 20081142 A1 PE20081142 A1 PE 20081142A1
Authority
PE
Peru
Prior art keywords
alkyl
enzyme inhibitors
indol
pyridinyl
cycloalkyl
Prior art date
Application number
PE2007001496A
Other languages
English (en)
Inventor
Mannching Sherry Ku
Frances Anne Donahue
Weiyi Li
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PE20081142A1 publication Critical patent/PE20081142A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

SE REFIERE A UNA COMPOSICION DE FORMULA I, DONDE R ES -(CH2)n-A, -(CH2)n-S-A Y -(CH2)n-O-A; A ES i O ii; D ES C1-C6 ALQUILO, C3-C6 CICLOALQUILO, -CF3, -(CH2)1-3-CF3; B Y C SON CADA UNO FENILO, PIRIDINILO, PIRIMIDINILO, FURILO, ENTRE OTROS; n ES 0-3; n1 ES 1-3; n2 ES 0-4, n3 ES 0-4; X1 ES UN ENLACE -S-, -O-, -S(O)-, ENTRE OTROS; R1 ES C1-C6 ALQUILO, C3-C6 CICLOALQUILO TETRAHIDROPIRANILO, ADAMANTILO, ENTRE OTROS; X2 ES -O-, -CH2-, -NH-, ENTRE OTROS; R2 ES UNA PORCION ANULAR DE FENILO, PIRIDINILO, FURILO, TIENILO, ENTRE OTROS; R3 ES HALOGENO, -CN, -CF3, -NH(C1-C6)ALQUILO, ENTRE OTROS; R4 ES H, CN, OH, C1-C6 TIOALQUILO, -NH-C(O)-N(ALQUILO C1-C3)2, ENTRE OTROS; R5 ES H, C1-C3 ALQUILO; R6 ES H C1-C6 ALQUILO. SON COMPUESTOS PREFERIDOS: ACIDO 4-(2-{5-CLORO-1-(DIFENILMETIL)-2-[2-({[2-(TRIFLUOROMETIL)BENCIL]SULFONIL}AMINO)ETIL]-1H-INDOL-3-IL}ETOXI)BENZOICO; ACIDO 4-(3-{1-BENZIHIDROL-5-CLORO-2-[2-(2-METIL-6-NITRO-FENILMETANSULFONILAMINO)ETIL]-1H-INDOL-3-IL}PROPIL)-BENZOICO; ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION Y COMPOSICIONES FARMACEUTICAS. DICHO COMPUESTO ES UN INHIBIDOR DE FOSFOLIPASAS Y ES UTIL COMO AGENTE TERAPEUTICO POR INTERFERIR EN LA RESPUESTA INFLAMATORIA
PE2007001496A 2006-10-31 2007-10-31 Formulaciones semisolidas de inhibidores de enzima fosfolipasa PE20081142A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85557106P 2006-10-31 2006-10-31

Publications (1)

Publication Number Publication Date
PE20081142A1 true PE20081142A1 (es) 2008-09-22

Family

ID=39345047

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007001496A PE20081142A1 (es) 2006-10-31 2007-10-31 Formulaciones semisolidas de inhibidores de enzima fosfolipasa

Country Status (10)

Country Link
US (1) US20100093725A1 (es)
EP (1) EP2068829A2 (es)
JP (1) JP2010508304A (es)
AR (1) AR063744A1 (es)
AU (1) AU2007313718A1 (es)
BR (1) BRPI0718042A2 (es)
CL (1) CL2007003146A1 (es)
PE (1) PE20081142A1 (es)
TW (1) TW200826932A (es)
WO (1) WO2008055148A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2614144B1 (en) 2010-09-08 2015-07-22 Twincore Zentrum für Experimentelle und Klinische Infektionsforschung GmbH Use of inhibitors of phospholipase a2 for the treatment or prevention of flavivirus infection
US9487039B2 (en) 2011-09-09 2016-11-08 Hewlett-Packard Development Company, Lp. Printer
GB201401904D0 (en) * 2014-02-04 2014-03-19 Ziarco Pharma Ltd Pharmaceutical composition for topical administration
CN113941003B (zh) * 2021-10-25 2023-04-28 江苏集萃新型药物制剂技术研究所有限公司 多聚段组合物、药物制剂及其组合物和制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622832A (en) * 1990-02-28 1997-04-22 Genetics Institute, Inc. Arachidonic acid releasing phospholipase A2 enzyme and methods of use
US5559158A (en) * 1993-10-01 1996-09-24 Abbott Laboratories Pharmaceutical composition
US20030104048A1 (en) * 1999-02-26 2003-06-05 Lipocine, Inc. Pharmaceutical dosage forms for highly hydrophilic materials
US20030235595A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Oil-containing, orally administrable pharmaceutical composition for improved delivery of a therapeutic agent
CN1399542A (zh) * 1999-09-27 2003-02-26 美国氰胺公司 药用载体制剂
US6352718B1 (en) * 1999-09-27 2002-03-05 American Cyanamid Company Vasopressin antagonist formulation and process
US6797708B2 (en) * 2001-12-03 2004-09-28 Wyeth Inhibitors of cytosolic phospholipase A2
US6984735B2 (en) * 2001-12-03 2006-01-10 Wyeth Process for making an aldehyde
US7605156B2 (en) * 2001-12-03 2009-10-20 Wyeth Methods for the use of inhibitors of cytosolic phospholipase A2
TW200510305A (en) * 2003-07-25 2005-03-16 Wyeth Corp Process for the preparation of CPLA2 inhibitors
US7582771B2 (en) * 2003-09-03 2009-09-01 Wyeth Process for the synthesis of cPLA2 inhibitors
US7342119B2 (en) * 2003-09-30 2008-03-11 Wyeth Holdings Corporation Process for the synthesis of a CPLA2 inhibitor
ATE382035T1 (de) * 2003-11-17 2008-01-15 Wyeth Corp Verfahren zur herstellung von n-substituierten phthalimiden
HN2004000536A (es) * 2003-12-16 2009-02-18 Wyeth Corp Un procediemiento de sintesis para la alquilacion reductiva de la posicon c-3 de indoles
AR048239A1 (es) * 2004-02-25 2006-04-12 Wyeth Corp Procesos para la preparacion de haluros de aril- y heteroaril-alquilsulfonilo e intermediarios de sintesis de los mismos
GT200500065A (es) * 2004-03-26 2005-10-24 Procedimientos para la preparacion de compuestos aminoarilos yodados
US20050244367A1 (en) * 2004-05-03 2005-11-03 Ilypsa, Inc. Phospholipase inhibitors localized in the gastrointestinal lumen
AR053410A1 (es) * 2004-08-19 2007-05-09 Wyeth Corp Proceso para la sintesis de indoles n-alquilados c-2, c-3 sustituidos. compuestos intermediarios
TW200718687A (en) * 2005-05-27 2007-05-16 Wyeth Corp Inhibitors of cytosolic phospholipase A2

Also Published As

Publication number Publication date
TW200826932A (en) 2008-07-01
WO2008055148A3 (en) 2008-11-06
AU2007313718A1 (en) 2008-05-08
AR063744A1 (es) 2009-02-18
US20100093725A1 (en) 2010-04-15
JP2010508304A (ja) 2010-03-18
WO2008055148A2 (en) 2008-05-08
EP2068829A2 (en) 2009-06-17
BRPI0718042A2 (pt) 2013-11-12
CL2007003146A1 (es) 2008-01-25

Similar Documents

Publication Publication Date Title
PE20090815A1 (es) Compuesto de amida
PE20061490A1 (es) Derivados de ciclohexanosulfonilo como inhibidores del transportador de glicina glyt1
PE20090219A1 (es) Compuestos mimeticos de glucocorticoides, metodos de preparacion y composiciones farmaceuticas
PE20090903A1 (es) Derivados de acido azabifenilaminobenzoico como inhibidores de la dihidroorotato deshidrogenasa
PE20080835A1 (es) Derivados novedosos de aminopiridina que tienen accion inhibidora selectiva sobre aurora a
PE20070593A1 (es) Compuestos pirrolopirimidina como inhibidores de syk
PE20060243A1 (es) Derivados de 4-amino insustituido-5-(4-urea-fenil)-pirrolotriazina
PE20020354A1 (es) Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
PE20090694A1 (es) Compuestos moduladores de sirtuinas
PE20060298A1 (es) Derivados de acido carboxilico de bencimidazolona
PE20141700A1 (es) Compuestos de 2-(2,4,5-anilino sustituido) pirimidina
PE20091682A1 (es) Compuestos de carbamoilo como inhibidores de dgat1 190
PE20110285A1 (es) Derivados de sulfonamidofenil propionamida como ligandos del receptor vaniloide del subtipo 1
PE20050018A1 (es) Compuesto pentaciclico heteroaromatico como inhibidor de la proteina tirosina fosfatasa 1b (ptb1b)
PE20070218A1 (es) COMPUESTOS DE CICLOALQUILO AMINO-HIDANTOINA Y USO DE ESTOS PARA LA MODULACION DE ß-SECRETASA
PE20060525A1 (es) Compuestos heterociclicos como inhibidores de cetp
AR051839A1 (es) Metodo para preparar n-fenilpirazol -1- carboxamidas
PE20091065A1 (es) Derivados bis-(sulfonilamino) en terapia 066
PE20060748A1 (es) Derivados de indolcarboxamida como inhibidores de quinasa ikk2
PE20061305A1 (es) Compuestos derivados de fenilacetamidas como inhibidores de proteincinasas
PE20060589A1 (es) FENILAMINOTIAZOLES SUSTITUIDOS COMO AGONISTAS DE ADENOSINA A1 Y A2b
PE20061348A1 (es) DERIVADOS DEL ACIDO PIRMIDINCARBOXILICO COMO MODULADORES DE PPAR-alfa
RS50918B (sr) Novi estri fluorenkarbonske kiseline, postupak za njihovo pripremanje, kao i njihova upotreba kao lekova
PE20051160A1 (es) DERIVADOS DE BETA-AMINOACIDOS COMO INHIBIDORES DEL FACTOR Xa
PE20070359A1 (es) Inhibidores de pirimidinilpirazol de aurora quinasas

Legal Events

Date Code Title Description
FA Abandonment or withdrawal